Biologic Treatments – Uveitis

In your Trust please supply the number of patients currently treated for Uveitis with a biologic treatment, including those on a Patient Access Scheme.

Please state the number of Uveitis patients treated, and where possible by each biologic drug:

  • Adalimumab
  • Etanercept
  • Infliximab
  • Rituximab
  • Other biologics

Please find below the number of patients under the care of the Trust Ophthalmology Department who have been treated with the listed treatments in Financial Year 2015-16. The indication for treatment is not recorded on the Trust Pharmacy dispensing system so it is not possible to identify patients who have been treated for uveitis. The data may, therefore, include patients who have been treated with these drugs for other indications than those listed in the request.

 

Patients under the direct care of Ophthalmology
Financial Year 2015-16 No Patients
Adalimumab 0
Etanercept 0
Infliximab 2
Rituximab 2

 

 

How many Psoriasis patients have been treated in the last 6 months with Fumaric acid esters (Fumaderm), If your trust can’t supply patients, please supply the number of packs of tabs

The Trust Pharmacy department has not supplied any patients in the last 6 months with Fumaric acid esters (Fumaderm).

©2017 Royal Surrey County Hospital

Log in with your credentials

Forgot your details?